Subscribe To
SNY / Why Sanofi Shares Are Trading Lower Today
SNY News
By The Motley Fool
November 3, 2023
This Stock Just Dropped By 15%: Is It a Buy?
Sanofi's third-quarter results weren't great, and the company announced a business separation. The biotech will lower its operating income margin targ more_horizontal
By Yahoo Finance
October 30, 2023
Sanofi stock recovers slightly after last week's plunge
Sanofi (SNY) shares are trending higher after plummeting last Friday, after the pharmaceutical company missed third-quarter earnings expectations, los more_horizontal
By Seeking Alpha
October 27, 2023
Sanofi (SNY) Q3 2023 Earnings Call Transcript
Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relation more_horizontal
By Zacks Investment Research
October 27, 2023
Sanofi (SNY) Beats on Q3 Earnings, to Spin-Off Consumer Unit
Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It announces plans to separate its Consumer unit into a new pub more_horizontal
By InvestorPlace
October 27, 2023
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
Sanofi (NYSE: SNY ) stock fell about 15% overnight after it predicted slower profit growth next year. The French drug company also said it will follow more_horizontal
By CNBC Television
October 27, 2023
Sanofi CEO Paul Hudson on Q3 results: Increased R&D spending will impact 2024 profit
Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, spin off of its consumer health care business, growth o more_horizontal
By Market Watch
October 27, 2023
Sanofi shares skid as French drugmaker outlines higher R&D expenses, taxes
Shares of French drugmaker Sanofi fell as much as 16% on Friday after after hiking its research-and-development expense guidance as well as its expect more_horizontal
By Reuters
October 27, 2023
Sanofi takes page from rivals' separation playbook
Sanofi on Friday mapped out a potential separate listing of its consumer healthcare business from the fourth quarter of next year, as it plans to shor more_horizontal